Ticker LaunchReverse merger · Completed · EDSA
Edesa Biotech Inc.
Reverse merger with Stellar Biotechnologies, Inc. (SBOT)
Edesa Biotech Inc. merged into Stellar Biotechnologies, Inc. (SBOT), a Nasdaq-listed maker of Keyhole Limpet Hemocyanin protein for immunotherapy, in a reverse merger that takes the private company public. The deal was announced on Mar 7, 2019 and closed on Jun 7, 2019. The combined company trades as Edesa Biotech, Inc. (EDSA) on Nasdaq.
Edesa Biotech is a clinical-stage biopharmaceutical company based in Ontario. It became public by acquiring Stellar Biotechnologies in a share exchange and focuses on developing and advancing its drug candidates.
- Status
- Completed
- Private company
- Edesa Biotech Inc.
- Public company
- Stellar Biotechnologies, Inc. (SBOT)
- Public company business before
- Nasdaq-listed maker of Keyhole Limpet Hemocyanin protein for immunotherapy
- Announced
- Mar 7, 2019
- Closed
- Jun 7, 2019
- Combined company
- Edesa Biotech, Inc. (EDSA)
- Exchange
- Nasdaq
- Sector
- Biotech & pharma
More on this deal for subscribers
- Ownership split between private and public holders
- Reverse stock split
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
Other completed reverse mergers
- Bangtong Technology International Limitedinto Sunrise Tours, Inc. · Jun 21, 2019
- Oncternal Therapeutics, Inc.into GTx, Inc. · Jun 7, 2019
- Red Cat Propware, Inc.into TimefireVR Inc. · May 15, 2019
- C3J Therapeutics, Inc.into AmpliPhi Biosciences Corporation · May 10, 2019
- China VTV Ltd. (Hong Kong target)into China VTV Limited · May 8, 2019
- Adynxx, Inc.into Alliqua BioMedical, Inc. · May 3, 2019